These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 29421493)
1. Preferential hepatic uptake of paclitaxel-loaded poly-(d-l-lactide-co-glycolide) nanoparticles - A possibility for hepatic drug targeting: Pharmacokinetics and biodistribution. Mandal D; Shaw TK; Dey G; Pal MM; Mukherjee B; Bandyopadhyay AK; Mandal M Int J Biol Macromol; 2018 Jun; 112():818-830. PubMed ID: 29421493 [TBL] [Abstract][Full Text] [Related]
2. A novel paclitaxel-loaded poly(d,l-lactide-co-glycolide)-Tween 80 copolymer nanoparticle overcoming multidrug resistance for lung cancer treatment. Yuan X; Ji W; Chen S; Bao Y; Tan S; Lu S; Wu K; Chu Q Int J Nanomedicine; 2016; 11():2119-31. PubMed ID: 27307727 [TBL] [Abstract][Full Text] [Related]
3. Formulation and evaluation of tacrolimus-loaded galactosylated Poly(lactic-co-glycolic acid) nanoparticles for liver targeting. Mistry NP; Desai JL; Thakkar HP J Pharm Pharmacol; 2015 Oct; 67(10):1337-48. PubMed ID: 25944126 [TBL] [Abstract][Full Text] [Related]
4. In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells. Gao C; Pan J; Lu W; Zhang M; Zhou L; Tian J Anticancer Drugs; 2009 Oct; 20(9):807-14. PubMed ID: 19696655 [TBL] [Abstract][Full Text] [Related]
5. Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer. Sun B; Ranganathan B; Feng SS Biomaterials; 2008 Feb; 29(4):475-86. PubMed ID: 17953985 [TBL] [Abstract][Full Text] [Related]
6. Paclitaxel-loaded poly(D,L-lactide-co-glycolide) nanoparticles for radiotherapy in hypoxic human tumor cells in vitro. Jin C; Bai L; Wu H; Liu J; Guo G; Chen J Cancer Biol Ther; 2008 Jun; 7(6):911-6. PubMed ID: 18367873 [TBL] [Abstract][Full Text] [Related]
7. Development of a novel morphological paclitaxel-loaded PLGA microspheres for effective cancer therapy: in vitro and in vivo evaluations. Zhang Z; Wang X; Li B; Hou Y; Yang J; Yi L Drug Deliv; 2018 Nov; 25(1):166-177. PubMed ID: 29299936 [TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cells loaded with paclitaxel-poly(lactic- Wang X; Gao J; Ouyang X; Wang J; Sun X; Lv Y Int J Nanomedicine; 2018; 13():5231-5248. PubMed ID: 30237710 [TBL] [Abstract][Full Text] [Related]
9. Poly(lactic- Kumar P; Singh AK; Raj V; Rai A; Keshari AK; Kumar D; Maity B; Prakash A; Maiti S; Saha S Int J Nanomedicine; 2018; 13():975-990. PubMed ID: 29497292 [TBL] [Abstract][Full Text] [Related]
10. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance. Liu Y; Pan J; Feng SS Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049 [TBL] [Abstract][Full Text] [Related]
11. Selective anticancer activity of hydroxyapatite/chitosan-poly(d,l)-lactide-co-glycolide particles loaded with an androstane-based cancer inhibitor. Ignjatović NL; Penov-Gaši KM; Wu VM; Ajduković JJ; Kojić VV; Vasiljević-Radović D; Kuzmanović M; Uskoković V; Uskoković DP Colloids Surf B Biointerfaces; 2016 Dec; 148():629-639. PubMed ID: 27694053 [TBL] [Abstract][Full Text] [Related]
13. A potential in situ gel formulation loaded with novel fabricated poly(lactide-co-glycolide) nanoparticles for enhancing and sustaining the ophthalmic delivery of ketoconazole. Ahmed TA; Aljaeid BM Int J Nanomedicine; 2017; 12():1863-1875. PubMed ID: 28331311 [TBL] [Abstract][Full Text] [Related]
14. Poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) nanoparticles for local delivery of paclitaxel for restenosis treatment. Westedt U; Kalinowski M; Wittmar M; Merdan T; Unger F; Fuchs J; Schäller S; Bakowsky U; Kissel T J Control Release; 2007 May; 119(1):41-51. PubMed ID: 17346845 [TBL] [Abstract][Full Text] [Related]
15. Biodegradable polymeric system for cisplatin delivery: development, in vitro characterization and investigation of toxicity profile. Alam N; Khare V; Dubey R; Saneja A; Kushwaha M; Singh G; Sharma N; Chandan B; Gupta PN Mater Sci Eng C Mater Biol Appl; 2014 May; 38():85-93. PubMed ID: 24656356 [TBL] [Abstract][Full Text] [Related]
16. Carboplatin loaded Surface modified PLGA nanoparticles: Optimization, characterization, and in vivo brain targeting studies. Jose S; Juna BC; Cinu TA; Jyoti H; Aleykutty NA Colloids Surf B Biointerfaces; 2016 Jun; 142():307-314. PubMed ID: 26970818 [TBL] [Abstract][Full Text] [Related]
17. Development of bicalutamide-loaded PLGA nanoparticles: preparation, characterization and in-vitro evaluation for the treatment of prostate cancer. Ray S; Ghosh Ray S; Mandal S Artif Cells Nanomed Biotechnol; 2017 Aug; 45(5):944-954. PubMed ID: 27327352 [TBL] [Abstract][Full Text] [Related]
18. Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs. Dong Y; Feng SS Biomaterials; 2005 Oct; 26(30):6068-76. PubMed ID: 15894372 [TBL] [Abstract][Full Text] [Related]
19. Cytotoxicity of Paclitaxel in biodegradable self-assembled core-shell poly(lactide-co-glycolide ethylene oxide fumarate) nanoparticles. He X; Ma J; Mercado AE; Xu W; Jabbari E Pharm Res; 2008 Jul; 25(7):1552-62. PubMed ID: 18196205 [TBL] [Abstract][Full Text] [Related]
20. A Promising Emodin-Loaded Poly (Lactic-Co-Glycolic Acid)-d-α-Tocopheryl Polyethylene Glycol 1000 Succinate Nanoparticles for Liver Cancer Therapy. Liu H; Gao M; Xu H; Guan X; Lv L; Deng S; Zhang C; Tian Y Pharm Res; 2016 Jan; 33(1):217-36. PubMed ID: 26334502 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]